Platinum-sensitive Ovarian Cancer

• CLINICAL_TRIALS research · 2026-04-08
  Clinical Trial Update: Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy [Phase 3]

  A Phase 3 trial comparing Rina-S plus standard of care versus standard of care for maintenance therapy in recurrent platinum-sensitive ovari…

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) [Phase 1, Phase 2]

  Genmab is conducting a Phase 1/2 clinical trial of Rinatabart Sesutecan for multiple advanced solid tumors; recruitment is ongoing.

• CLINICAL_TRIALS research · 2025-12-19
  Clinical Trial Update: RESCUE Study (REcurrent Ovarian Cancer Secondary Cytoreduction Using Chemotherapy rEsponse) [Phase 2]

  This is a Phase 2 clinical trial update for the RESCUE study evaluating secondary cytoreduction using chemotherapy response in recurrent, pl…

• CLINICAL_TRIALS trial_result · 2025-04-16
  Clinical Trial Update: Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer [Phase 2]

  Phase 2 clinical trial evaluating AK112 in combination with chemotherapy and/or Olaparib for platinum-sensitive ovarian cancer; recruitment …

• CLINICAL_TRIALS trial_result · 2022-12-15
  Clinical Trial Update: Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer [Phase 2]

  Phase 2 trial comparing Folate Receptor Alpha Peptide Vaccine with GM-CSF versus GM-CSF alone in platinum-sensitive ovarian cancer was termi…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2021-09-02
  Clinical Trial Update: A Study to Assess the Efficacy and Safety of Farletuzumab (MORAb 003) in Combination With Carboplatin Plus Paclitaxel or Carboplatin Plus Pegylated Liposomal Doxorubicin (PLD) in Participants With Low CA125 Platinum-sensitive Ovarian Cancer [Phase 2]

  Phase 2 trial evaluating farletuzumab with carboplatin/paclitaxel or carboplatin/PLD in platinum-sensitive ovarian cancer in first relapse; …

• CLINICAL_TRIALS trial_result · 2019-05-01
  Clinical Trial Update: A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer [Phase 3]

  Phase 3 trial updating maintenance niraparib versus placebo in platinum-sensitive ovarian cancer has completed; results posted in 2019.

• CLINICAL_TRIALS trial_result · 2018-02-07
  Clinical Trial Update: Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy [Phase 3]

  A Phase 3 trial evaluating olaparib as maintenance therapy in BRCA-mutated, platinum-sensitive ovarian cancer patients who achieved complete…